Legislation

Colorado Senate Nixes Cigar Tax Proposal

May 3, 2019 | By Andrew Nagy
Colorado Senate Nixes Cigar Tax Proposal

Colorado Senators have struck down a measure that sought to ask voters to approve a tax increase on handmade cigars and other nicotine products.

The Senate rejected the proposed ballot initiative and therefore the issue will not appear on this November’s ballot.

The bill, which was introduced on April 24, looked to raise the state cigar tax from 40 percent to 62 percent of the manufacturer’s price. Additionally, the bill called for a tax hike on cigarettes, e-cigarettes and other nicotine products.

Colorado Gov. Jared Polis supported the piece of legislation, and in an official statement said that he was “disappointed by the decision to take this choice out of the hands of Colorado voters.”

More in Legislation

See all
Florida Lawmaker Files Measure Urging Members to Support Cigar-Exemption Bills

Florida Lawmaker Files Measure Urging Members to Support Cigar-Exemption Bills

Rep. Anthony Sabatini (R-32) introduced a memorial bill yesterday in the Florida House that encourage…

Jan 15, 2020
Tobacco 21: Retailers Respond

Tobacco 21: Retailers Respond

With the stroke of a pen, the legal age to buy tobacco anywhere in the U.S. became 21 immediately …

Jan 7, 2020
FDA Says Premium, Handmade Cigars Are ‘Lowest Priority’

FDA Says Premium, Handmade Cigars Are ‘Lowest Priority’

The U.S. Food and Drug Administration issued a new guidance last week citing handmade cigars as the …

Jan 6, 2020
Congress Raises Tobacco-Purchase Age to 21

Congress Raises Tobacco-Purchase Age to 21

The legal age to purchase tobacco products, including handmade cigars, in the United States will be …

Dec 20, 2019
Senate Confirms Hahn as New FDA Head

Senate Confirms Hahn as New FDA Head

The Senate today confirmed by a vote of 72 to 18 that Dr. Stephen Hahn will be the new commissioner …

Dec 12, 2019
FDA Extends Comment Period for Cigar Approval Rule Proposal

FDA Extends Comment Period for Cigar Approval Rule Proposal

Originally set to end today, the FDA says it will continue accepting public feedback until December …

Nov 25, 2019